Market by Product, Application, End-user, and Country | Forecast 2021-2028
As per Triton’s research
report, the pharmaceutical continuous manufacturing market in Europe is
anticipated to advance at a CAGR of 10.08% in revenue during the reviewed years
2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this
market include:
• The UK
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
In Europe, the studied market
is likely to experience substantial growth over the considered years. This
progress is motivated by the surge in demand for technologically advanced
systems, an increase in the preference for continuous manufacturing, and the
availability of continuous manufacturing systems. Additionally, the presence of
prominent players adds to the growth of the pharmaceutical continuous manufacturing
market across the region.
Germany, for instance, is
among the top locations for research, production, and distribution of
pharmaceuticals. Moreover, exceptional research units, the presence of renowned
scientists, and the well-developed pharmaceutical industry, have transformed
Germany into a unique business location. Additionally, the growing population
has created several challenges, resulting in the high demand for pharmaceutical
products. Above all, there is a steady shift from batch to continuous
manufacturing over the years, which is likely to boost Germany’s pharmaceutical
continuous manufacturing market’s progression in the next few years.
On the other hand, France is
one of the largest consumers of pharmaceutical products. Moreover, the
country’s pharmaceutical sector garners significant revenue, ranking fourth
globally in prescription medicines. Additionally, the massive production of
active pharmaceutical ingredients is likely to help develop continuous
manufacturing in pharmaceuticals, in turn, boosting the pharmaceutical
continuous manufacturing market on a growth path.
GEA Group AG is involved in
offering process technology and components for several industries, including
food, pharmaceutical, transportation, and personal care industries. Its product
portfolio entails chillers and heat pumps, automation systems, brewing systems,
ice machines, separation equipment, cleaners & sterilizers, and others.
Moreover, the company has advanced its technologies and methods over the years,
owing to its vigorous R&D activities. It has headquarters located in
Germany, with business operations spread across multiple regions.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1.
THREAT OF NEW ENTRANTS
2.1.2.
THREAT OF SUBSTITUTE PRODUCTS
2.1.3.
BARGAINING POWER OF BUYERS
2.1.4.
BARGAINING POWER OF SUPPLIERS
2.1.5.
COMPETITIVE RIVALRY
2.2. IMPACT
OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
2.3. LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
INSIGHTS
2.7. MARKET
DRIVERS
2.7.1.
RISE IN INITIATIVES BY REGULATORY AUTHORITIES
FOR THE ADOPTION OF CONTINUOUS MANUFACTURING
2.7.2.
SURGING ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS
MANUFACTURING SYSTEMS
2.7.3.
RISING HEALTHCARE EXPENDITURE
2.8. MARKET
RESTRAINTS
2.8.1.
RISING CUSTOMER EXPECTATIONS FOR BETTER
MEDICINES
2.9. MARKET
OPPORTUNITIES
2.9.1.
SURGE IN THE MANUFACTURING OF LARGE MOLECULES
AND BIOLOGICS
3.
EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
OUTLOOK - BY PRODUCT
3.1. INTEGRATED
CONTINUOUS SYSTEM
3.2. SEMI-CONTINUOUS
SYSTEM
3.3. CONTROL
& SOFTWARE
4.
EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
OUTLOOK - BY APPLICATION
4.1. FINAL
DRUG PRODUCT MANUFACTURING
4.2. API
MANUFACTURING
5.
EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
OUTLOOK - BY END-USER
5.1. PHARMACEUTICAL
COMPANIES
5.2. CONTRACT
MANUFACTURING ORGANIZATIONS
5.3. OTHER
END-USERS
6.
PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET -
EUROPE
6.1. COUNTRY
ANALYSIS
6.1.1. GERMANY
6.1.2. FRANCE
6.1.3. UNITED KINGDOM
6.1.4. ITALY
6.1.5. RUSSIA
6.1.6. SPAIN
6.1.7. REST OF EUROPE
7.
COMPANY PROFILE
7.1. HOSOKAWA MICRON
CORPORATION
7.2. GEA GROUP AG
7.3. LB BOHLE MASCHINEN +
VERFAHREN GMBH
7.4. THERMOFISHER SCIENTIFIC
INC
7.5. SIEMENS HEALTHINEERS
7.6. ELI LILLY & COMPANY
7.7. PFIZER INC
7.8. GLATT GMBH
7.9. SYNTEGON (FORMERLY
BOSCH PACKAGING TECHNOLOGY)
7.10. GEBRUDER LODIGE
MASCHINENBAU GMBH
7.11. KORSCH AG
7.12. COPERION GMBH
7.13. MUNSON MACHINERY
COMPANY
8.
RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1.
OBJECTIVES OF STUDY
8.1.2.
SCOPE OF STUDY
8.2. SOURCES
OF DATA
8.2.1.
PRIMARY DATA SOURCES
8.2.2.
SECONDARY DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1.
EVALUATION OF PROPOSED MARKET
8.3.2.
IDENTIFICATION OF DATA SOURCES
8.3.3.
ASSESSMENT OF MARKET DETERMINANTS
8.3.4.
DATA COLLECTION
8.3.5.
DATA VALIDATION & ANALYSIS
TABLE 1: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 3: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 4: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 5: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 3: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $
MILLION)
FIGURE 6: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $
MILLION)
FIGURE 9: EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 10: GERMANY PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 11: FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 12: UNITED KINGDOM PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 13: ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 14: RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 15: SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 16: REST OF EUROPE PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)